You Should Watch These: Movado Group (NYSE:MOV), TransCanada Corporation (NYSE:TRP), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Incyte Corporation (NASDAQ:INCY)

Posted by on Apr 01, 2016

NN Inc. (NASDAQ:NNBR) shares advanced 3.64% in last trading session and ended the day at $13.68. NNBR Gross Margin is 21.20% and its has a return on assets of -0.90%. NN Inc. (NASDAQ:NNBR) quarterly performance is -13.67%.

NN, Inc., (NASDAQ: NNBR) announced that it will begin production of a new series of Cylindrical Roller Bearing cages that utilizes a proprietary process technology. NN developed this technology at one of its R&D innovation centers and has been working closely with major bearing suppliers to validate the new process. The flexible manufacturing technology allows bearing manufacturers to replace expensive machined cages resulting in significant cost savings. It also reduces tooling costs and shortens lead times on samples providing customers a cost effective fast to market solution for their cylindrical bearing applications.

Movado Group, Inc. (NYSE:MOV) ended the last trading day at $27.53. Company weekly volatility is calculated as 4.31% and price to cash ratio as 3.50. Movado Group, Inc. (NYSE:MOV) showed a weekly performance of -6.74%.

Movado Group (NYSE: MOV) reported Q4 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $143.3 million versus the consensus estimate of $140.7 million. Movado Group sees FY2017 EPS of $1.85 – $2.00, versus the consensus of $2.27. Movado Group sees FY2017 revenue of $585 – $600 million, versus the consensus of $615.3 million.

On 31 March, TransCanada Corporation (NYSE:TRP) shares advanced 0.41% and was closed at $39.31. TRP EPS growth in last 5 year was -24.50%. TransCanada Corporation (NYSE:TRP) year to date (YTD) performance is 21.99%.

TransCanada Corp. (NYSE:TRP) plans to sell as much as 49 percent of its five Mexico natural gas pipelines to a passive partner to help pay for the $10.2 billion purchase of Columbia Pipeline Group Inc.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares fell -2.84% in last trading session and ended the day at $26.30. VRX Gross Margin is 74.80% and its has a return on assets of -0.70%. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) quarterly performance is -74.06%.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that, as anticipated and consistent with its previously disclosed intention, it has launched the process to obtain an amendment and waiver to its credit facility.

Incyte Corporation (NASDAQ:INCY) caters to the Healthcare space. It has a net profit margin of 0.90% and weekly performance is 7.47%. On the last day of trading company shares ended up at $72.47.

Incyte Corporation (Nasdaq: INCY) announces that ten abstracts featuring data from its emerging development portfolio will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans, Louisiana from April 16–20, 2016. These abstracts include data from the Company’s monoclonal antibody agonist programs targeting GITR and OX40 as well as its small molecule inhibitor programs targeting LSD1, BRD (BET), PI3Kδ and JAK1.

Leave a Reply

Your email address will not be published. Required fields are marked *